Controversal aspects in standardization of susceptibility testing on yeasts to azoles;KONTROVERSEN BEI DER STANDARDISIERUNG DER EMPFINDLICHKEITSPRUFUNG VON HEFEN GEGEN AZOL-ANTIMYOTIKA

Mycoses, Supplement

Volumn 39, Issue 2, 1996, Pages 22-26

  Tintelnot, Kathrin ^a   Seibold, M ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Azoles; Fluconazole; Itraconazole; Standardization; Susceptibility testing

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; PYRROLE;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG SCREENING; DRUG SENSITIVITY; HYDROPHOBICITY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; STANDARDIZATION; YEAST;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA; FLUCONAZOLE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL;

EID: 0030438416     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. National Committee for Clinical Laboratory Standards (1992): Reference method for broth dilution antifungal susceptibility testing of yeasts; Proposed Standard. NCCLS document M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
2. National Committee for Clinical Laboratory Standards (1995): Reference method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Tentative Standard. NCCLS document M27-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.
3. Polak, A., Ansorg, R., Bartmann, K., Dermoumi, H, Hantschke, D., Plempel, G. Schar, G. & Tarbuc, M. (1987): Multicenter-Studie zur Standardisierung der Empfindlichkeitsbestimmung von Pilzen gegen 5-Fluorcytosin und Amphotericin B. mykosen 30, 306-314.
4. Rex J. H., Pfaller, M. A, Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993): Antifungal Susceptibility Testing. Clin. Microbiol. Rev. 6, 367-381.
5. Seibold, M., Tintelnot, K. & Muller, B. (1994): Die Empfindlichkeitsprüfung von Candida-Arten und Cryptococcus neoformans gegen Azole im Mikrodilutionstest. 28. wissenschaftl. Tagung der Deutschsprachigen Mykologischen Gesellschaft, Montreux 29.Sept.-2. Okt.1994 (Vortrag).
6. Odds, F.C., De Backer, T, Dams, G., Vranckx, L. & Woestenborghs, F. (1995): Oxygen as limiting nutrient for growth of Cryptococcus neoformans.J. Clin. Microbiol 33, 995-997.
7. Seibold, M. & Werner, E. (1995): Testing susceptibility of Candida species to fluconazole and itraconazole using the microdilution assay, mycoses 38, 443-148.
8. Rodriguez-Tudela,J. L. & Martinez-Suarez.J. V (1995): Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2 % glucose on the selection of endpoint criteria. J. Antimicrob Chemother 35, 739-749.
9. Pfaller, M. A., Dupont, B., Kobayashi, G. S , Müller, J., Rinaldi, M. G., Espinel-Ingroff, A, Shadomy, S., Troke, P.F., Walsh, T.J. & Warnock, D. W. (1992): Standardized susceptibility testing of fluconazole: an international collaborative study Antimicrob. Agents ChemotIher. 36, 1805-1809.
10. Mutler, J. (1992): Resistenzphänomene bei systemisch wirksamen Antimykotika und das Problem der Empfindlichkeitsprüfiing. mycoses 25 (suppl.), 1-7.
11. Viviani, M. A., Tortorano, A M., Brasca, M, Cogliati, M. (1995): Candida susceptibility to fluconazole. Comparison of E-Test and disc diffusion with agar dilution method 2nd meeting of the European Confederation of Medical Mycology (ECMM), april 27-29, 1995, Brussels, Belgium. (Poster)
12. Fothergill, A. W. (1996): Laboratory methods in antifungal susceptibility testing. "Focus on fungal infections 6", march 6-8, 1996, New Orleans, Louisiana, USA, pp. 31-33.
13. Polak, A. (1989): Die antimykotische Chemotherapie opportunistischer Pilzinfektionen. Habilitationsschrift. Edition Roche, Basel.
14. Martinez-Suarez, J.V & Rodriguez-Tudela J. L (1995): Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from spain. Antimicr Agents Chemoth. 39. 1512-1516.